IAS2013: Study shows starting treatment earlier reduces HIV reservoir, improves health over time
7th International AIDS Society Conference, Kuala Lumpur, June 2013: A French study shows that people who start HIV treatment with CD4 counts above 500 had much lower HIV reservoir levels and higher CD4 counts over time than those who started below 500. Researchers followed 309 people…Read More
7th International AIDS Society Conference, Kuala Lumpur, June 2013: Results from a study in London shows a high rate of re-infection with hepatitis C (HCV) in 858 gay men living with HIV. A total of 145 men were followed who had a documented date of an…Read More
IAS2013: New integrase inhibitor dolutegravir shows potent suppression with few side effects
7th International AIDS Society Conference, Kuala Lumpur, June 2013: The new integrase inhibitor dolutegravir showed better suppression of HIV at 48 weeks than raltegravir (Isentress). Other benefits from taking the once-a-day pill included fewer people who had uncontrolled HIV and who had developed drug resistance. The…Read More
IAS2013: Novel scoring system in early infection may help predict who should start treatment sooner
7th International AIDS Society Conference, Kuala Lumpur, June 2013: A non-randomized Swiss study of 290 people showed that using a novel scoring system of six surrogate markers could help establish best practices for starting HIV meds in early infection — an area of HIV care that…Read More
IAS2013: FibroScan can predict risk of liver damage among people with HIV and hepatitis C
7th International AIDS Society Conference, Kuala Lumpur, June 2013: Researchers from a Spanish study reported on a non-invasive way to measure liver stiffness that may help predict the risk of liver disease progression in people who are co-infected with HIV and hepatitis C. This method, called…Read More
IAS2013: Life expectancy for people with HIV jumps 15 years, but not equally for everyone
7th International AIDS Society Conference, Kuala Lumpur, June 2013: In results from a study by the NA-ACCORD, researchers reported that the life expectancy of HIV-positive people on treatment in North America increased 15.3 years between 2000–2002 and 2006–2007. The study further suggests that a 20-year-old HIV-positive…Read More
IAS2013: Study shows low but detectable HIV levels in semen of some men despite being “undetectable” in blood
7th International AIDS Society Conference, Kuala Lumpur, June 2013: Reflecting the results reported from a few other studies, the French ANRS EP49 study showed that despite having well controlled blood viral load, nearly 1 in 10 HIV-positive men who have sex with men had a low…Read More